Abstract
Cytochemistry is the discipline that is applied to visualize specific molecules in individual cells and has become an essential tool in life sciences. Immunocytochemistry was developed in the sixties of last century and is the most frequently used cytochemical application. However, metabolic mapping is the oldest cytochemical approach to localize activity of specific enzymes, but in the last decades of the previous century and the first decade of the present century it almost became obsolete. The popularity of this approach revived in the past few years. Metabolism gained interest as player in chronic and complex diseases such as cancer, diabetes, neurodegenerative diseases, and vascular diseases and both enzyme cytochemistry and metabolic mapping have become important tools in life sciences.
In this chapter, we present glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most prevalent enzyme deficiency worldwide, to illustrate recent developments in enzyme cytochemistry or metabolic mapping. The first assays which were developed quantified enzyme activity but were unreliable for single cell evaluation. The field has expanded with the development of cytochemical single cell assays and DNA testing. Still, all assays—from the earliest developed tests up to the most recently developed tests—have their place in investigations on G6PD activity. Recently, nanoscopy has become available for light and fluorescence microscopy at the nanoscale. For nanoscopy, cytochemistry is an essential tool to visualize intracellular molecular processes. The ultimate goal in the coming years will be nanoscopy of living cells so that the molecular dynamics can be studied. Cytochemistry will undoubtedly play a critical role in these developments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heilemann M (2010) Fluorescence microscopy beyond the diffraction limit. J Biotechnol 149(4):243–251. doi:10.1016/j.jbiotec.2010.03.012
Galbraith CG, Galbraith JA (2011) Super-resolution microscopy at a glance. J Cell Sci 124(Pt 10):1607–1611. doi:10.1242/jcs.080085
Hell SW (2009) Microscopy and its focal switch. Nat Methods 6(1):24–32. doi:10.1038/nmeth.1291
Gomori G (1939) Microtechnical demonstration of phosphatase in tissue sections. Exp Biol Med 42(1):23–26
Van Noorden CJ (2010) Imaging enzymes at work: metabolic mapping by enzyme histochemistry. J Histochem Cytochem 58(6):481–497. doi:10.1369/jhc.2010.955518
Van Noorden CJ (2014) Metabolic mapping by (quantitative) enzyme hystochemistry. In: McManus L, Mitchell R (eds) Pathobiology of human disease. Elsevier, San Diego, CA, pp 3760–3774
Bleeker FE, Atai NA, Lamba S et al (2010) The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol 119(4):487–494. doi:10.1007/s00401-010-0645-6
Koehler A, Van Noorden CJ (2003) Reduced nicotinamide adenine dinucleotide phosphate and the higher incidence of pollution-induced liver cancer in female flounder. Environm Toxicol Chem 22(11):2703–2710
Luzzatto L (2006) Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica 91(10):1303–1306
Howes RE, Piel FB, Patil AP et al (2012) G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9(11), e1001339. doi:10.1371/journal.pmed.1001339
Nkhoma ET, Poole C, Vannappagari V et al (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cell Mol Dis 42(3):267–278. doi:10.1016/j.bcmd.2008.12.005
Peters AL, Van Noorden CJ (2009) Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem 57(11):1003–1011. doi:10.1369/jhc.2009.953828
Guindo A, Fairhurst RM, Doumbo OK et al (2007) X-Linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med 4(3), e66. doi:10.1371/journal.pmed.0040066
Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371(9606):64–74. doi:10.1016/S0140-6736(08)60073-2
Meletis J, Konstantopoulos K (2004) Favism—from the “avoid fava beans” of Pythagoras to the present. Haematology 7(1):17–21
Beutler E (2008) Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111(1):16–24. doi:10.1182/blood-2007-04-077412
Dern R, Weinstein IM, Leroy G et al (1954) The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaqulne-sensitive individuals. J Lab Clin Med 43(2):303–309
Crosby WH (1956) Favism in Sardinia (newsletter). Blood 11(1):91–92
Sansone G, Segni G (1958) New aspects of the biochemical alterations in the erythrocytes of patients with favism; almost complete absence of glucose-6-phosphate dehydrogenase. Boll Soc Ital Biol Sper 34(7):327
Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372–373
Rattazzi MC (1968) Glucose 6-phosphate dehydrogenase from human erythrocytes: molecular weight determination by gel filtration. Biochem Biophys Res Commun 31(1):16–24
Luzzatto L, Battistuzzi G (1985) Glucose-6-phosphate dehydrogenase. Adv Hum Genet 14:217–329
Wrigley NG, Heather JV, Bonsignore A et al (1972) Human erythrocyte glucose 6-phosphate dehydrogenase: electron microscope studies on structure and interconversion of tetramers, dimers and monomers. J Mol Biol 68(3):483–499
Marks PA, Johnson AB, Hirschberg E (1958) Effect of age on the enzyme activity in erythrocytes. Proc Natl Acad Sci U S A 44(6):529–536
WHO Working Group (1989) Glucose-6-phosphate dehydrogenase deficiency. B World Health Organ 67(6):601–611
Beutler E (1994) G6PD deficiency. Blood 84(11):3613–3636
World Health Organization (1967) Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO Scientific Group. W Health Organ Tech Rep Ser 366:1–53
LaRue N, Kahn M, Murray M et al (2014) Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 91(4):854–861. doi:10.4269/ajtmh.14-0194
Nantakomol D, Paul R, Palasuwan A et al (2013) Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency. Malar J 12:289. doi:10.1186/1475-2875-12-289
Jonges GN, Hagen H, Van Noorden CJ et al (1989) Comparison between the chromate inhibition test and a cytochemical method for the determination of glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Clin Chim Acta 181(2):135–141
Wolf BH, Weening RS, Schutgens RB et al (1987) Detection of glucose-6-phosphate dehydrogenase deficiency in erythrocytes: a spectrophotometric assay and a fluorescent spot test compared with a cytochemical method. Clin Chim Acta 168(2):129–136
Van Noorden CJ, Vogels IM, James J et al (1982) A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. I. Optimalization of the staining procedure. Histochemistry 75(4):493–506
Van Noorden CJ, Vogels IM (1985) A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 60(1):57–63
Persico MG, Viglietto G, Martini G et al (1986) Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5′ non-coding region. Nucleic Acids Res 14(6):2511–2522
Trask BJ, Massa H, Kenwrick S et al (1991) Mapping of human chromosome Xq28 by two-color fluorescence in situ hybridization of DNA sequences to interphase cell nuclei. Am J Hum Genet 48(1):1–15
Martini G, Toniolo D, Vulliamy T et al (1986) Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J 5(8):1849–1855
Minucci A, Moradkhani K, Hwang MJ et al (2012) Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cell Mol Dis 48(3):154–165. doi:10.1016/j.bcmd.2012.01.001
Von Seidlein L, Auburn S, Espino F et al (2013) Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J 12:112. doi:10.1186/1475-2875-12-112
Van Noorden CJ, Dolbeare F, Aten J (1989) Flow cytofluorometric analysis of enzyme reactions based on quenching of fluorescence by the final reaction product: detection of glucose-6-phosphate dehydrogenase deficiency in human erythrocytes. J Histochem Cytochem 37(9):1313–1318
Shah SS, Diakite SA, Traore K et al (2012) A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep 2:299. doi:10.1038/srep00299
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Peters, A.L., van Noorden, C.J.F. (2017). Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes. In: Pellicciari, C., Biggiogera, M. (eds) Histochemistry of Single Molecules. Methods in Molecular Biology, vol 1560. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6788-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6788-9_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6787-2
Online ISBN: 978-1-4939-6788-9
eBook Packages: Springer Protocols